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ABSTRACT
Fungal metabolism of halogenated and related steroids was
investigated. The fungi Aspergillus niger ATCC 9142, Curvularia lunata
NRRL 2380 and Rhizopus stolonifer ATCC6227b were studied in this regard.
2l-Fluoro-, 2l-chloro, 2l-bromo- and 2l-methyl-pregn-4-ene-3,20-
diones were prepared and incubated with ~ niger (a C-2l-hydroxylator)
in order to observe the effect of the C-2l substituent on the metabolism
of these substrates. In all four cases, the C-2l substituent prevented
any significant metabolism of these substrates.
llB-Fluoropregn-4-ene-3,20-dione was prepared and incubated with
C. lunata (an llB-hydroxylator) and ~ stolonifer (an lla-hydroxylator).
With ~ lunata, the ll-fluoro- substituent prevent hydroxylation at
the 11 position, but diverted it to a site remote from the fluorine atom.
In contrast, with ~ stolonifer the llB-fluoro- substituent, although
slowing the apparent rate of hydroxylation, did not prevent its occurrence
at the 11a- position.
llB-Hydroxypregn-4-ene-3,20-dione was also incubated with R.
stolonifer. The llB-hydroxy-;group did not appear to have any significant
effect on hydroxylation at the lla- position.
The incubation of a substrate, unsaturated at a favoured site of
hydroxylation with Rhizopus arrhizus ATCC 11145 provided a complex mixture
of products; among them were both the a and S epoxides. The formation
of these products is rationalized as arising because of the lack of
regio- and stereospecificity of the hydroxylase enzyme(s) involved.
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1INTRODUCTION
The adrenocortical hormones
The steroids are members of a large class of compounds which possess
the perhydro-l~2-cyclopentenophenanthracenering system 11] as a common
feature. The steroids include a wide variety of naturally occurring and
synthetic substances such as sterols, bile acids, adrenocortical hormones~
sex hormones, various contraceptive drugs, cardiac glycosides, insect
molting hormones and antibiotics.
The two carbon acetate is the biosynthetic precursor of the steroids
and the familiar sterol, cholesterol [8] is the prime source of all
steroids in the human organism. Cholesterol is biosynthesized through
a complex series of 25 reactions involving the participation of 18
acetate units.
Steroid nomenclature is based upon the nature of the hydrocarbon
framework from which the steroid is derived. Individual compounds are
named systematically as derivatives of steroidal hydrocarbons. The more
important of these are formulated and numbered below (Fig. 1). The
carbon atoms are numbered in a predetermined sequence beginning with
ring A. The Greek letter ~ indicates a double bond as does the suffix
-ene. Substituents attached to the ring system from above are designated
f3 (solid line), those attached from below are designated Ct (dotted line).
This study deals only with steroids having the androstane [4] and
pregnane [5] skeleton.
2Figure 1. Common steroid skeleton
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3In the next few pages, a brief introduction is given regarding the
discovery of the glucocorticoid hormones and their synthetic analogues.
Although the glucocorticoid hormones are not directly related to the
present study, two aspects in their development, namely the discovery of
the widespread microbiological transformation of steroids and the
observation that the introduction of a halogen in the steroid nucleus
had a dramatic effect on the physiological activity of these new
analogues, are important and as such the following brief account should
put this study in context.
1In 1927, Rogoff and Stewart extracted fresh dog adrenal glands and
found that the clear extract could be injected intravenously into
adrenalectomized dogs (see below) without any evident ill effect. (Human
adrenal glands are small organs weighing about 6 g each located near the
upper end of each kidney.) Rogoff and Stewart also observed that double
adrenalectomized dogs (dogs in which both adrenals had been removed)
survived an average of 7-10 days after surgery. They also observed that
of 30 adrenalectomized dogs injected with the adrenal extract, 6
survived 18-78 days artd the rest compared favorably with the controls.
Thus it was concluded that the adrenal extract in some unknown way
prolonged the life of the animals in the absence of their adrena1s.
Over the next decade, several groups2,3 tried successfully to
isolate the individual components of the adrenal extract and by 1943,
no less than 28 steroids had been isolated. 4 The list includes estrone
[9], androstenedione [10], progesterone [11], a number of compounds
having no known biological activity and six ~4-3-ketosteroids soon
HO
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o
o
'androst-4-ene- (10)
3,17-dione
progesterone [11]
5recognized as having one or another type of activity specific to the
adrenal function. The six biologically active compounds having the
114-3-ketone function are all progesterone derivatives and all contain
the a keto1 side chain differing only in the nature of the function at
ell and Cl7 (Fig. 2).
In the decade that followed the discovery of the above compounds, no
very significant use was indicated. Investig.ation of the biological
action of individual compounds disclosed that they possess, in varying
degrees, activities of several types.
In tests measuring ability to increase survival of adrenalectomized
an.imals, the highly oxygenated cortisone [12] and cortisol [13] showed
only low order of activity, whereas cortexone [17], the least oxygenated
5
was very potent.
A significant function of $ome of the compounds listed in Figure 2
is their ability to promo~e deposition of glycogen in the liver. This
liver glycogen or glucocorticoid activity is highest for cortisol [13]
and cortisone [12], whereas cortexone [17] is, inactive. Another
manifestation of activity of the steroids in Figure 2 is their ability
to control the balance of body fluids. A substance is said to have
electrolytic metabolic activity or mineralocorticoid activity if it
promotes increased retention of Na+, CI- and water and excretion of K+.
Such manifestation leads to edema which is usually objectionable.
Cortexone [17] has the highest activity of this type.
The varied manifestation of biological activity did not suggest any
further therapeutic application of the active compounds in Figure 2 and
the substances which appeared most interesting because of their high
6Figure 2. Glucocorticai hormones
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7carbohydrate activity were not available by isolation in amounts adequate
for ,exploratory clinical experimentation. The striking application to
therapy that eventually ensued developed as the result of extensive
chemical investigation starting with the elucidation of the structures.
By the late 1940's, the structures shown in Figure 2 had all been
elucidated and it was established that cortisol [13] was the most
important adrenocortical hormone. 6
In 1949, clinical tests performed by Hench 7aand Kendall revealed
that cortisone [12] was a powerful drug in the treatment of rheumatoid
arthritis. This discovery provided a strong incentive for further
research directed towards the efficient and inexpensive preparation of
this hormone. One major problem encountered in attempts to prepare
cortisone from the available steroids was how to efficiently introduce
the biologically necessary o~ygen at carbon 11. Although many chemical
approaches were tried, they were generally long and inefficient.
8The important discovery by an Upjohn group headed by D. H. Peterson
that the soil fungus Rhizopus arrhizus introduces an hydroxy group at
carbon 11 of progesterone [11] in 50% yield provided the breakthrough
needed to accomplish the efficient synthesis of cortisone [12]. Shortly
thereafter, many other organisms were discovered which were able to
introduce the C-ll hydroxy group more efficiently. The fungus Rhizopus
nigrans produces lla-hydroxyprogesterone [18] from progesterone [11] in
80-90 percent yield. 8,9
It soon became apparent that treatment of rheumatoid arthritis with
cortisone [12} only alleviates rather than cures the disease. Therefore,
it was necessary for treatment to continue over protracted time periods.
8[ 18]
OH
o
()
OH
[ 20]
9After cortisone [12] had been used for some time in the treatment of
rheumatoid arthritis, undesireable side effects became evident with
increasing frequency, particularly on long term usage.
The cortical hormones have a wide spectrum of activity and the small
concentrations normally maintained by the adrenal cortex regulates a
variety of metabolic processes that are essential to life. Therefore
when cortisone [12] and cortisol [13] are applied at dosage levels
necessary to suppress the symptoms of rheumatoid arthritis, some of the
metabolic effects may reach abnormal proportions. Therefore, side effects
such as excessive sodium retention and potassium excretion, negative
nitrogen balance, increased gastric activity, edema and psychosis are
exaggerated manifestations of the normal metabolic functions of the
7bhormones.
The hope thus arose that some modification of structure might make
possible a separation of the undesireable side effects from the anti-
rheumatic activity or at least produce a shift in the relative intensities
of the two types of action. Many attempts were made at modifying the
structure of cortisol, but the resulting products generally had lower
anti-rheumatic activity than cortisol itself.
Another breakthrough came about when it was accidentally discovered
that the introduction of a fluorine atom at the C9 position of cortisol
increased the potency of this new analogue ten-fold, making this new
analogue,; 9a-fluorocortisol [19] effective at one-tenth the dosage of
· 1 10cort~so . This new analogue, however, was not free of harmful side
effects since it resulted in an increased mineralocorticoid activity,
10
that is the causation of the retention of salt and water. This property
is objectionable since it leads to edema.
The introduction of the other halogens, chlorine~ bromine and iodine
at the 9a-position of cortisol also provided new analogues with anti-
inflammatory activity although their activities were lower than that of
cortisol.
After the above discovery, much effort was expended by many
investigators trying to introduce the halogens at other positions of the
steroid nucleus. The introduction of a fluorine atom at the l2a position
of cortisol was reported to have the same effect on glucocorticoid
t · tI • t d tI t h 9 .. 11aClvlty as lnro uctl0n ate a-posltl0n. Surprisingly enough,
introduction of a chlorine at the same position shows no appreciable
.. · · h hI··d h d·· 12actlvlty ln elt er t e g ucocortlcol or t e so lum retentl0n tests.
The introduction of a fluorine atom, at the 6a position of cortisol
increased the anti-inflammatory activity by a factor of 10_12. 13 ,14 Also,
the replacement of the 2l-hydroxy group of cortisol by a fluorine atom
resulted in an increase of 3-5 times the glucocorticoid activity.lS The
same substitution in progesterone [11] increased the progestational
activity by a factor of 2_416 Subsequently, other functional groups were
introduced along with the halogens to further separate the undesireable
side effects from the desired ones. A good example is triamcinolone
(9a-fluoro-llS,16a,17a,2l-tetrahydroxypregn-l,4-diene-3,20-dione [20])
which has the original cortisol structure and has been modified at 3
positions; the introduction of the l6a-hydroxy group decreased the salt
retaining properties that usually accompany the introduction of an
halogen atom. At the same time, the introduction of the Cl-C2 double
11
bond (accomplished microbiologically) also increased the anti-inflammatory
activity with a coneommitant decrease in the undesireable salt-retaining
side effects. 17
The hydroxylation of steroids
It was mentioned earlier that the discovery of a strain of the
Rhizopus species that could hydroxylate the steroid nucleus at carbon-II
helped resolve the problem of preparing cortisol and cortisone economically
from abundantly available starting materials. After the above discovery,
much time was invested in screening micro-organisms that were able to
functiIDnalize the steroid nucleus at various positions and in various
ways. Today, micro-organisms are known which can transform steroids in
numerous ways. The many types of transformation known are listed below. 18a
1. OXIDATIONS
hydroxylation
dehydrogenation
epoxidation
oxidation of alcohols to ketones and aldehydes
oxidation of ketones to esters and lactones
oxidation of sulfides to sulfoxides
oxidation of amines to ketones
2. REDUCTIONS
reduction of ketones, aldehydes and acids to alcohols
reduction of double bonds
reduction of bromide
12
3. ESTERIFICATION, AMIDE FORMATION AND HYDROLYSIS
hydrolysis of esters to steroidal alcohols
hydrolysis of oxides to alcohols
hydrolysis of acetals to steroidal alcohols
N-acylation of amines
4. ISOMERIZATION
5. RESOLUTION OF RACEMIC MIXTURES
The hydroxylation and dehydrogenation reactions are currently the
most important commercially. This is, of course, due to their role in
the partial synthesis of the adrenocortical hormones and their analogues.
The hydroxylation reaction is unique among the transformations listed
above inasmuch as no particular substrate is required except saturation
at the site to be hydroxylated.
The microbial enzymes display a formidable, widespread and remarkable
ability to hydroxylate steroids. That the reactions are indeed enzymic
has been proved in several cases by the isolation of the crystalline
enzymes from the microbial species and by subsequent transformation of
the steroid in vitro using the crystalline enzyme and an added reagent.
The resulting transformations were identical with those obtained eJ;Ilploying
the intact microbial systems with the same substrate. 19 At present,
reports have been made claiming the observation of microbial hydroxylation
at almost all positions of C21steroids as shown in Figure 3. 18b ,35
However despite the vast number of papers that have been published
on microbial hydroxylation of steroids, and despite their continuing
13
Figure 3. Positions of normal C-21 steroids reported to be
h d 1 d b · · 18a,35y roxy ate y mlcro-organlsms
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industrial importance, many aspects of steroidal hydroxylation remain
obscure. The enzyme mechanisms of steroid hydroxylation have been
studied intensively in various mammalian systems for many years. Later
investigation on microbial conversion of these compounds has added to
the elucidation of steroid metabolism and its enzymic basis. However,
much work remains to be done before the detailed mechanism. of steroidal
hydroxylation is fully understood.
The pioneering. work on the mechanism of steroid hydroxylation was
carried out by Hayano and his collaborators. 20 They used beef adrenal
homogenates to lIS-hydroxylate a variety of steroids which were saturated
at carbon-II. On the basis of tracer studies, it was established that
the oxygen of the hydroxyl group originated from molecular oxygen and
not from water or any other oxygen-containing compound present in the
medium; thus, when l7a,21-dihydroxy-pregn-4-ene-3,20-dione [14] was
incubated with beef adrenal homogenate and H2180, the product cortisol
[13] contained only normal amounts of 180. When, on the other hand,
2l-hydroxypregn-4-ene-3,20-dione [17] was incubated in 1802 atmosphere
with the same enzyme preparation, all the newly incorporated isotope was
found to reside in the newly introduced lIS-hydroxy group of
11S,21-dihydroxypregn-4-ene-3,20-dione [16].
It was then easily shown that the source of the oxygen of the
hydroxyl group was the same for microbial hydroxylation of steroids. 2l ,22
It was also shown that the 9(11) unsaturated analogues remained unaffected
when incubated with beef adrenal homogenate, thus making them unlikely
intermediates in the lIS-hydroxylation of [14] and [17]. Similarly,
15
neither 17a,21-dihydroxypregn-4,g(11)-diene-3,20-dione [21] nor
pregn-4,16-diene-3,20-dione [22] was transformed when incubated with
micro-organisms which hydroxylate the corresponding steroids at the
110, and 160, positions.
Still more evidence was obtained through the findings of Bloom
and Shul123 that micro-organisms convert double bonds into oxides rather
than alcohols. They fermented l7a,21-dihydroxypregn-4,9(11)-diene-
3,20-dione [21) with the 11S-hydroxylating fungus Curvularia lunata
and obtained the 9B,llS-oxido-17a,2l-dihydroxypregn-4-ene-3,20-dione
[23]. Similarly, 17a,21-dihydroxypregn-4,14-diene-3,20-dione [24] w,as
converted by the same fungus into 14a,15a-oxido-17a,21-dihydroxypregn-
4-ene-3,20-dione [25].
As a result of the above findings, Bloom and Shull postulated
that ,a micro-organism that is capable of introducing an axial hydroxyl
group at en is also capable of converting a dehydro- substrate into
an oxide also axial at Cn - This deduction is consistent with the
1?revious finding that incubation of 121] with the equatorial
11~-hydrQxylating fungus Aspergillus nidulans failed to produce [26J.
The use of tritiated and deute.rated substrates provided more
info'nnat.ionregarding the stereochemistry of the enzymic hydroxylation.
Pregnane.-3,20-dione.-l1a3H,12a,3H was incubated with Rhizopus nigricans wh.ich
provide.d an lla-hydroxy-de,rivative wh,ich showed a loss of 69% of the
()
01-1
OH
16
OH
OH
()
[ 24]
oH
o
[25J
17
total count of the substrate. After mild oxidation of this product,
essentially no change in the counts were observed. On the other hand,
when progesterone-lla3H,12a 3H was perfused through surviving adrenals, it
yielded two lIS-hydroxy analogues, namely cortisol [13] and corticosterone
[16]. No loss of the total substrate count was observed at this step,
b t h 70% d b -d - -·h h - -d24 ,25u t ere was a·o ecrease on su sequent OXl atlon Wlt . c romlC aCl
(Fig. 4).
25In a subsequent study progesterone-l1a3H,12a3H was incubated
with Calonectria decora, an organism which dihydroxy1ates certain steroids
at the 12S and 150. positions. The isolated dihydroxy metabolite showed
essentially no loss in activity in comparison with the original count of
the substrate. Mild oxidation by chromic acid of the metabolite to the
corresponding 11,15-dioxo analogue resulted in the loss of 30% of the
original count (see Fig. 4).
The above fl'indings demonstrated that the stereochemistry of the
carbon atom which is hydroxy1ated is always preserved. The newly formed
hydroxyl group has the same configuration as the hydrogen it replaced.
Hence the lla-hydrogen is transformed to the lla-hydroxyl and the
lIS-hydrogen into the lIS-hydroxyl group. The above findings were
further confirmed by the use of deuterium labelled substrates. Corey
et a1. 26 incubated 11S-deuterated progesterone [28] with Rhizopus nigrans
and obtained lla-hydroxypregn-4-ene-3,20-dione-llS2H [29] (label retained).
From the above studies it seems possible that hydroxylation at
saturated carbons of the steroid nucleus proceeds by direct electrophilic
insertion of an oxygen atom into a C-H bond as shown in Figure 5.
18
Figure 4. Use of tritiated substrates in elucidating the mechanism of
lla- and lIS-hydroxylation of steroids (see text for details).
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Figure 5. Stereospecific hydroxylation of steroids
o
enzyme
20
l8bHowever, it has been suggested that at sites in the steroid nucleus
adjacent or vinylogous to a carbonyl function, a quite different
mechanism may be op~rative.
The proposal has been made that at the C-2,6,17 and 2l-positions of
~43,20-diketo steroids, the carbon to be hydroxylated is first activated
by enolization and then hydroxylation occurs by electrophilic attack of
oxygen at the enol (Fig. 6). 27However, studies by Holland ~ ale using
the fungus Aspergillus niger, a C-2l hydroxylator,and 2l-d-progesterone
[30] as substrate did not support the above proposal of enzyme partici-
pation in enol fonnation during 21-hydroxylation. They found that either
of the two prochiral hydrogens of [30] could be lost with equal facility;
therefore, the products obtained from the incubation were a diastereomeric
monodeutero-alcohol mixture and the unlabelled 2l-hydroxyprogesterone
[17]. Also, the magnitude of the deuterium isotope effect of 1.3 is not
consistent with the proposal that an enolic intermediate is involved in
C-21-hydroxylation.
Further studies were carried out to investigate the above proposal
using steroids having the ~4-3-keto function and the fungus Rhizopus
arrhizu8., an organism known to hydroxylate the 6(3-positions of
A4 3 k sterol-ds. 28- 30 Th · b· f - 1 t f thu - ... eto e lncu atlon 0 equlmo ar arnoun s 0 e
enol acetate [31] and l6-d-androst-4-ene-3,17-dione (50% d) [32] with
Rhizopus arrhizus pr0Y'.ided 6(3-hydroxyandrost -4-ene-3 ,17-dione [33] with
a deuterium content of 18 percent. The observation was made that if
[31] was hydrolysed to androst-4-ene-3,17-dione [10] prior to hydroxylation
then a deuterium content of 25 percent or greater should be observed in
21
Figure 6. Suggested mechanism
for hydroxylation of steroids
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the product. The observed 18 percent strongly suggests that an enolic
intermediate is involved since [31] is metabolized more rapidly than the
31parent substrate [10].
Further evidence supporting an enolic intermediate was obtained
through the incubation of 68- and 6a-halogenated substrates. 32 The
incubation of 6S-ch1oroandrost-4-ene-3,17-dione [34] with ~ arrhizus
provided the lla-hydroxy1ated product and small amounts of the 6a-chloride
[38] along with some recovered starting material. In contrast, the
incubation of the 6S-fluoro analogue [35] gave androst-4-ene-3,6,17-
trione [36] and 3S-hydroxyandrost-4-ene-6,17-dione [37] among other
products. The corresponding 6a-halo substrates were recovered largely
unchanged although small amounts of [36] were obtained in each case. The
products [36], [37] and [38] were rationalized as arising from
protonation, electrophilic oxidation and/or hydration of the halo-enol
intermediates as shown in Figure 7.
More evidence (be it circumstantial) supporting an enolic intermediate
during 6S-hydroxylation of ~4-3-keto steroids is gained from the
observation that incubation of a large number of steroids having the
~4-3-ketofunctionwith ~ arrhizus invariably gave a 6(3-hydroxylated
*d h d· 9,28,29,30 h * b * fsterol among t e pro ucts w ereas lncu atlon 0
17S-hydroxyandrostan-3-one [39] (C4-CS double bond absent) with the same
34fungus gave only the lla- and 6a-monohydroxylated products. Studies
investigating whether hydroxylation at the C2 and Cl7 positions occurs
through an enolic intermediate have not been encountered.
Until recently, the majority of the substrates investigated in fungal
transformation of steroids possessed the ~4-3-keto function. This was due
o [ 36]
()
24
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~
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o
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o
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Figure 7. Proposed mechanism for the metabolism of
6-halo-androst-4-ene-3,20-dione by Pillizopus arrhizus
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almost entirely to the medicinal importance of steroids having this
function. The ~4-3-keto function appears to have placed some restriction
on the position of the steroid nucleus that could be hydroxylated. Thus
many fungi have acquired labels indicative of the position they most
frequently hydroxylate; the lla-hydroxylator is an organism which
frequently hydroxylates the lla position.
Lately, however, a large number of steroidal products have been
isolated from incubations with substrates lacking the ~4-3-keto function. 3S
From observation of these products, it became apparent that the position
of hydroxylation in many cases may well depend on the position of the
substituent in the steroid nucleus. It was observed that by systematically
changing the positions of the oxygenated substituents around the steroid
skeleton, it was sometimes possible to direct hydroxylation to certain
positions. 36- 38 The pattern of hydroxylation is therefore influenced by
the substituents ·present in the substrate. This point is illustrated by
the observation that incubation of di-ox.ygenated Sa-androstanes having a
carbonyl at C3 with the fungus Calconectriadecora gave products
hydroxylated in ring D mainly at CIS. On the other hand, substrates
having the carbonyl at el7 provided products hydroxylated at carbon-l
and _6. 37
Other fungi have a marked tendency to hydroxylate at a certain
position irrespective of the substituents present. One such fungus is
Aspergillus ochraceus which lla-hydroxylates many different substrates
and only hydroxylates other positions if carbon-II is occupied. 39
. 40 41One suggest10n ' that has been put forward regarding the pattern
of hydroxylation observed in many fungi is that the substrate may bind
27
to the surface of the hydroxylating enzyme at any of three sites in a
triangular arrangement outlined in Figure 8. Each site has both binding
and hydroxylating capabilities. The substrate's keto or hydroxy function
may bind to one or two sites (depending on how many oxy groups are
present). The enzyme then proceeds to hydroxylate the C-H bond(s) that
approach the vicinity of the third site.
This model, although simplistic, is supported by the observation
that many fungi have a great propensity for hydroxylating apical positions
of the triangle. There is also the tendency for many fungi to di-
hydroxylate Inono-oxygenated substrates and mono-hydroxylate di-oxygenated
substrates at the apices of the triangle or at sites close to them.
A fairly large accumulation of evidence suggests that many enzymes
responsible for steroidal hydroxylations are inducible. It has been
shown that certain substrates were 11S- and14a-hydroxylated with cell
free extracts of the fungus Curvularia lunata only if the enzyme(s)
-bi f- - d d - h - 11 42-44responS1 e were 1rst ln uce 1n t e lntact ces.
It is sometimes necessary for the "right" structural features to be
present in the substrate before a particular hydroxylation will occur.
For example, it is necessary for di-oxygenated androstane substrates to
possess an oxygen at carbon-II before 6S-hydroxylated products are
39
obtained when incubated with Aspergillus ochraceus. Also, the
introduction of a second double bond can influence the proportion and
types of products obtained: rac-17S-hydroxyestra-4,8(14)-diene-3-one
[40] incubated with ~ lunata afforded rac-7a,IOS- and lIS-mono-
45hydroxylated products, whereas rac-17S-hydroxyestra-4-ene-3....one [41]
provided resolved 10S-, 12a- and 14a-monohydroxy and racemic 6S- and
28
Figure 8. Arrows indicate approximate positions where the steroid may
bind to or be hydroxylated by the enzyme. The steroid may
bind in the normal (A) or reverse (B) phase.
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7B-monohydroxy derivatives. 46
The majority of the studies dealing with substituent effects on the
pattern of hydroxylation were carried out with oxygenated groups being the
substituent of interest. Although many halogenated steroids have been
used as substrates, only a few systematic studies have dealt with the
. 47 48
effect halogenated substituents have on the pattern of hydroxylatlon '
and there have been even fewer studies dealing with the effect halogen
substitution has on the metabolism of medicinally important ~4-3-keto
steroids.
The intent of the present study 'vas to investigate the effect
placement of the halogen at favoured sites of hydroxylation had on the
pat tern of fungal me,tabolism of !::J.4-3-keto steroids.
The first'systematic study dealing with the effects halogeno"
suhstituents had on fungal metabolism of steroids was undertaken by
47Jones and coworkers. They observed that the microbiological effect of
the halogeno substitue,nt depends on its nature, position and configuration
in the steroid nucleus. The effect of configuration was illustrated by
the observation that incubation of 3a-fluoroandrostan-7-one [42] with
the fungus Calconectria decora provided products hydroxylated at the
lS- and 6S-positions similar to the parent ketone whilst the 3S-isomer
was poorly metabolized.
The metabolism of the 3a-chloro and 3a-bromo analogues resembles
that of the 3a-fluaro derivative while the 3S-chloro and -bromo isomers
were utilized more rapidly than the parent ketone. These observations
exemplify the influence of the nature of the halogen on the metabolism of
the substrate. It was also observed that l7a-chloro-5a-androstan-3-one [L~3]
31
[44]
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is not metabolized by the same fungus, whereas the l7a-fluoro analogue
is dihydroxylated at the l2S- and lSa-positions similar to the parent
ketone.
I b d b h 48 · b d hn a su sequent stu y y t e same group, lt was 0 serve t at
introduction of a fluorine atom at favoured sites of hydroxylation
resulted (with few exceptions) in hydroxylation at sites remot'e from the
fluorine atom. This point is illustrated by the finding that incubation
o'f 12,12-difluoro-Sa-androstan-17-one [44] with Aspergillus ochraceus
(a fungus with a marked propensity for lla-hydroxylation) gave the
7a-hydroxylated product. Thus the conclusion was made that the tendency
of the fluorine atom to inhibit hydroxylation at or adjacent to the
carbon atom to which it is bonded outweighs the directing effects of the
keto group or the site specificity of the micro-organism. It was also
ob'served that a fluorine atom at a site remote from the favoured 'site of
oxidation facilitates hydroxylation.
In the present study, !:l4-3-keto steroids, halogenated and in one case
methylated at favoured sites of hydroxylation were prepared and incubated
with three different fungi. As mentioned before, 'it was of interest to
observe any effects the halogens might have on the pattern of metabolism
of such substrates. Although many medicinally important 114-3-keto-
halogenated steroids have been used successfully in excess of two decades,
there is a scarcity of information regarding the metabolism of these
steroids.
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EXPERIMENTAL
Apparatus, Materials and Methods
Melting points were determined on a Gallenkamp melting point
apparatus and are uncorrected. Infrared spectra were recorded with a
Perkin-Elmer 237B grating infrared spectrophotometer, l H NMR spectra with
a Bruker WP-60 or a Varian A60 using CDC13 or DMSO-d6 as solvent and TMS
as the internal standard. 15.08 MHz 13 C NMR Bpectra~"were recorded with a
Bruker WP-60 using CDC13 or DMSO-d6 as solvent and TMS as internal
standard. Mass spectra were obtained with an AEI MS30 double beam mass
spectrometer at 70 eVe Column chromatography was performed on silica gel,
thin layer chromatography on Merck sflica gel 60-F254 (0.25 mm thick).
The plates were examined under UV light or sprayed with a 80% concentrated
sulfuric acid/ethanol solution and developed at 110°C. Preparative tIc
was performed on Merck silica gel". F254 (2.0 mm thick) and was examined
under UV light. Elemental analyses were performed by Guelph Chemical
Laboratories Ltd., Guelph, Ontario.
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Preparation of steroidal substrates
21-Methanesu1fony1oxypregn~4-ene-3,20-dione[45]51
5 g (0.015 moles) of 21-hydroxypregn-4-ene-3,20-dione [17] was added
to 12 mL of dry pyridine and the mixture cooled to -10°C. 1.73 g
(0.015 moles) of methanesulfonyl chloride was added and the mixture
stirred below -5°C for 1.25 hours. The reaction was stopped by the
addition of ether and water. The white precipitate was filtered and
recrystallized from methanol giving 4.2 g (67% yield) of the title
compound, m.p. l57-160°C (lit. 52 l56-l57°C). The IH NMR spectrum
included signals at 0 0.75 (3H,s C18H) , 1.23 (3H,s C19H) , 3.27 (3H,s
methyl of sulfonate group), 4.78 (2H,s C2lH) , 5.73 (lH,s C4H). Mass
spec. M/e (%): 408 (5), 393 (2), 366 (10),330 (20),299 (100).
21-Chloropregn-ene-3,20-di~ne[46]
The procedure followed in the preparation of [45] was also used in
the preparation of this substrate except in this case the reaction was
performed at room temperature. 5.0 g (0.015 moles) of 2l-hydroxypregn-
4-ene-3,20-dione [17] was added to 10 mL of dry pyridine. The mixture
was cooled to O°C and 2.16 g (0.019 moles) of methanesulfonyl chloride
was added. The mixture was stirred while warming to room temperature
for two hours, at which time the product had precipitated and the
solution had acquired a pinkish colour. Water was added and the
chloride filtered. Recrystallization was effected from methanol (3 times)
to give 3.8 g (73% yield) of the title compound, m.p. 203-205°C (lit. 53
206-208°C). The IH ~1R spectrum included signals at 0 0.71 (3H,s C18H) ,
1.20 (3H,s C19H), 4.12 (2H,s C2lR) , 5.75 (lR,s C4H). Mass spec.
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M/e (%): 350 (8), 348 (25), 333 (8),314 (16), 312 (2~), 299 (100).
13 C ID1R data is located in Table 1.
2l-Fluoropregn-4-ene-3,20-dione [47]54
4 g (0.69 moles) of potassium fluoride and 6 g (0.023 moles) of
l8-crown-6-ether (1,4,7,10,13,16-hexaoxacyclooctadecane [73], obtained
from Aldrich Chemical Company) were suspended in 25 mL of freshly
distilled DMF. 3.5 g (0.0085 moles) of 2l-methanesulfonyloxypregn-
4-ene-3,20-dione [45] was added and the mixture refluxed at water
aspirator pressure for 21 hours. Water and ether were added and the
precipitated product filtered. The product was chromatographed on a
silica gel column by stepwise elution from benzene to ether (increments
of 10% ether). The title compound was recrystallized from acetone giving
1.0 g (35% yield), m.p. 138-140°C (lit. 16 141.5-142 .2°C). The IH mlR
spectrum included signals at 8 0.72 (3H,s C18H), 1.20 (3H,s C19H), 4.79
(2H,d C2lH) , 5.82 (lH,s C4H). Mass spec. r'1/e (%): 332 (100),317 (24),
299 (26), 290 (100). 13C NMR data may be found in Table 1.
21-Bromopregn-4-ene-3,20-dione [48]51
2.5 (0.006 moles) of 21-methanesulfonyloxypregn-4-ene-3,20-dione
[45] was added to 15 roL of acetone. After the solution was complete
3.5 g (0.63 moles) of lithitUl1 bromide was added and the mixture refluxed
with stirring for 2 hours. After cooling, the white solid was collected,
dissolved in chlo'rofonn, washed with water and dried (anhydrous soditnn
sulfate). After removal of the chloroform, recrystallization was
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effected from acetone giving 1.8 g (76% yield) of the title compound,
m.p. 159-162°C (lit. 56 190-191°C). The IH NMR spectrum included signals
at 8 0.72 (3H,s C18H) , 1.20 (3H,s C19H), 3.96 (2H,s C2lH) , 5.79 (lH,s
C4H). Mass Spec. Mle (%): 394 (16), 392 (17), 352 (28),350 (27),
313 (53), 299 (100). 13C mm. data are located in Table 1.
Pregn-4,9(11)-diene-3,20-dione [49]57
15 g (0.045 moles) of lla-hydroxypregn-4-ene-3,20-dione [18] was
dissolved in 85 mL of methylene chloride and 14.5 g (0.076 moles) of
diethyl-(2-chloro-l,1,2-trifluoroethyl)amine [50] was added. After 24
hours, at -20°C, the solvent was removed under reduced pressure and
recrystallization of the product effected from 95% ethanol giving 10 g
(first crop). A second crop provided 1.6 g giving a total yield of
11.6 g (81%), m.p. 122-124°C (lit. 57 123-125°C). The I H NMR spectrum
included signals at 8 0.65 (3H,s C18H) , 1.35 (3H,s C19H) , 2.14 (3H,s
C21H) , 5.55 (lH,t CllH) , 5.73 (lH,d C4H). Mass spec 1':1/e (%): 312 (89),
297 (100), 269 (28). 13C NMR data is located in Table 1. Note: tIc
shows this reaction is complete after 15 minutes when performed at room
temperature.
9a-Bromo-11S-fluoropregn-4-ene-3,20-dione [51]59
To 40 mL of dry tetrahydrofuran was added 50 mL of the 70% HFI
pyridine reagent. The mixture was cooled to -SO°C and 3.5 g of N-bromo-
succinimide followed by 5.5 g of [49] in 10 mL of THF was added. The
mixture was stirred at the same temperature for one hour and then
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allowed to sit at room temperature for another hour, after which cold
saturated sodium carbonate solution was added cautiously until the
solution was slightly basic. The product was extracted with methylene
chloride, and after drying (sodium sulfate) and removal of the methylene
chloride, the product was recrystallized from methanol giving 6.1 g
(84% yield), m.p. l43-l45°C (lit. 60 l45-150°C). The In NMR spectrum
included signals at 0 0.81 (3H,d C18H) , 1.39 (3H,d C19H) , 2114 (3H,s
C21H) , 5.15 (lH,m lIaR), 5.69 (lR,s C4H). Mass spec. M/e (%): 412
(7),410 (8), 331 (19),312 (100),269 (24). 13 C NMR data are presented
in Table 1.
llB-fluoroEregn-4-ene-3,20-dione [52]61
To 25 mL of dry THF was added 2.8 g of [51], 10 mL of tri-n-
butyltin hydride and 10 mg of azoisobutyronitrile. The mixture was
allowed to sit at room temperature for five hours, after which time a
few drops of water were added and the solvent removed under reduced
pressure.
Recrystallization of the residue from an 85% ethanol/water mixture
provided 1.95 g (86% yield) of the title compound, m.p. l69-l72°C
(lit. 62 156-l58°C). The I H NMR spectrum included signals at 8 0.81 (3H,d
C18H) , 1.36 (3R,d C19H) , 2.14 (3H,s C21H) , 5.13 (lH,m lIaR), 5.71 (lR,s
C4H). Mass spec. M/e (%): 332 (54), 317 (10), 312 (100), 304 (16),
297 (46). The 13 C NMR data is presented in Table 1.
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Androst-4-ene-3-one-178-carboxylic acid [53]63
2.0 g of 21-hydroxypregn-4-ene-3,20-dione [17] was added to 25 mL
of acetone containing one drop of sulfuric acid. 2.0 g of paraperiodic
acid (HSI06) in 6 mL of water was then added and the solution refluxed
for 12 hours. The acetone was removed under reduced pressure and
chloroform (50 m~ added. The chloroform solution was then extracted
with 4% sodium hydroxide solution (3 times). Fresh chloroform was added
to the aqueous extract and the mixture acidified with dilute hydrochloric
acid. The nlixture was then extracted with chloroform (3 times) and after
drying (sodium sulfate), the chloroform was removed to give 1.4 g (73%
yield) of the title compound, m.p. 246-250°C (lit. 64 246-250°C). The IH
NMR spectrum included signals at 0 0.75 (3H,s C18H), 1.20 (3H,s C19),
5.65 (lR,s e4H). Mass spec. M/e (%): 316 (57), 301 (18), 298 (13),
283 (14), 274 (100). 13C Nl1R data are presented in Table 1.
. 65 6621-Methylpregn-4-ene-3,20-dl0ne [55] ,
To 30 mL of dry benzene was added 0.6 g of the previously prepared
acid [53]. Nitrogen was bubbled through the suspension for 15 minutes
and after cooling the mixture to 5°C, 2mL of oxalyl chloride was added.
The mixture was stirred while allowing to warm to room temperature and
after 45 minutes, the solution was complete. The solvent was removed
under vacuum and the residual acid chloride [54] was dried in vacuo for
a further 6 hours. Dry hexamethylphosphoric triamide (HMPA) (10 mL)
was added to the residue and after the solution was complete, 0.56 g of
tetraethyltin and 10 mg of benzylchlorobis(triphenylphosphine) palladium
II [56] was added. The mixture was placed in a water bath at 80 0 e and
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heating continued at this temperature for 45 minutes. The darkened
mixture was cooled to room temperature and water added. The products
were extracted with ether and after washing the ether solution with
2% sodium hydroxide and drying with anhydrous sodium sulfate, the
solution was concentrated. The residue was chromatographed on
preparative tIc silica gel plates using 30% ethyl acetate/benzene
solution as the developing solvents. The desired product was
recrystallized from methanol/water solution to give 0.21 g (42% yield)
of the title compound, m.p. l39-l4l o C (lit. 67 l5l-l52°C). The IH NMR
spectrum included signals at 0 0.66 (3H,s C18H) , 1.19 (3H,s C19) , 1.04
(3H,t C22H), 5.74 (lH,s C4H). Mass spec. M/e (%): 328 (64), 313 (24),
299 (59), 283 (73), 271 (100). 13C NMR data are presented in Table 1.
3,20-Bisethylene ketal of Pregn-4-ene-3,11,20-trione [56]68
To 100 mL of toluene was added 10.1 g of pregn-4-ene-3,11,20-trione
[57], 15 mL of ethylene gl¥col and 0~17 g of p-toluenesulfonic acid
monohydrate. The mixture was refluxed with stirring while the water
formed d'uring the reaction was removed by a Dean Stark water trap.
After 20 hours, the mixture was cooled and 50 mL of methanol containing
1 g of KOH was added. The organic layer was washed with water (3 times)
and the washings further extracted with chloroform. The combined mother
liquor and the chloroform extract were dried (anhydrous sodium sulfate)
and after removal of the solvent, recrystallization was effected from
methanol giving 9.1 g of the title compound. M.p. l77-l79°C (lit. 68
l76-l79°C). The IH NMR spectrum included signals at 0 0.73 (3H,s C18H) ,
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1.22 (3H,s C19H), 1.25 (3H,s C21H), 3.93 (8H,s ethylene H), 5.30 (lH,s
C6H). Mass spec. M/e (%): 416 (100),401 (34), 388 (17), 372 (21),
357 (24), 328 (13).
11S-Hydroxypregn-4-ene-3,20-dione [58]58
8.9 g of the above prepared bisethy1ene ketal [56] was added to
400 mL of a 80% aqueous t-butanol solution. The mixture was warmed until
the solution was complete and then cooled to room temperature. 9.36 g
of sodium borohydride was added and stirring continued at room temperature
for 24 hours. The solvent was then removed under reduced pressure and
chloroform (200 mL) was added to the residue. After washing (water) and
drying (anhydrous sodium sulfate), the chloroform was removed. To the
residue was added 250 mL of methanol and 0.5 mL of concentrated sulfuric
acid. The mixture was refluxed for 3 hours and then cooled to room
temperature and the solution neutralized by the addition of saturated
sodium hydrogen carbonate solution. The product was extracted (3 times)
with chloroform and after drying (anhydrous sodium sulfate) the solvent
was removed. The product was recrystallized from a methanol/water
mixture to give 6.5 g of the title compound, m.p. l85-l88°C (lit. 68
186-188°c). The IH NMR spectrum included signals at 8 0.91 (3H,s C18H),
1.45 (3H,s C19H), 2.12 (3H,s C21R), 4.39 (lH,m lIaR), 5.66 (lR,s C4H).
~1ass spec. ~1/e (%): 330 (16), 312 (22), 297 (17), 269 (10), 124 (100).
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3-Ethoxyandrosta-3,5-diene-17-one [59]69
To 15 mL of dry dioxane was added 2.0 g of androst-4-ene-3,17-dione,
2 mL of triethyl orthoformate and 0.15 g of p-toluenesulfonic acid
monohydrate. The mixture was stirred at room temperature for 1.5 hours
after which time the solution had darkened. One mL of pyridine and 10
roL of water were added and the mixture cooled in an ice/water bath for
several hours. After precipitation was complete, the solid was filtered
and the product recrystallized from methanol containing a trace of
pyridine to give 1.82 g of the title compound, m.p. l50-l52°C (lit. 70
152°C). The 1,H NMR spectrum included signals at 80.91 (3H,x C18H) , 1.00
(3H,s C19H) , 1.30 (3H,t methyl of ethoxy group), 3.78 (2H,q methylene of
ethoxy group), 5.17 (2H,m C4H, C6H).
Androst-4,6-diene-3,17-dione [60]69
4.65 g of 3-ethoxyandrosta-3,5-diene-17-one [59] was added to
170 mL of 95% aqueous acetone solution. When the solution was complete,
3.6 g of 2,3-dichloro-5,6-dicyanoquinone (DDQ) [61] in 30 mL of 95%
aqueous acetone was added portionwise. After the addition of DDQ was
complete (3 min), the reaction mixture was allowed to stir for a
further 5 minutes. After the addition of 70 mL of acetone, the solvent
was removed and 200 mL of chloroform added. The chlorofonn solution was
cooled and then filtered. The filtrate was washed with water (3 times),
1% ,aqueous sodium hydroxide solution (3 times) and water (3 times).
The chloroform solution was dried (sodium sulfate) and concentrated.
The crude product was filtered through an alumina column (neutral, 100 g)
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eluted with acetone. The product was recrystallized from ethyl acetate
giving 3.0 g of the title compound, m.p. l69-l7l o C (lit. 69 l69-l70°C).
The IH NMR spectrum included signals at 0 0.97 (3H,s C18H), 1.13 (3H,s
C19H), 5.72, 6.12 (2H,s C6H, C7H), 6.12 (Ill,s C4H). Mass spec. M/e (%):
284 (100), 269 (17), 254 (9). 13C NMR data are presented in Table 1.
m-chloroperbenzoic acid was then added portionwise over a ten minute
period with stirring. After the solution was complete, 0.6 g of
anhydrous sodium sulfate was added and stirting continued at room
temperature for 21 hours. The precipitated m-chlorobenzoic acid was
filtered and the filtrate cooled to -20°C. After a second filtration,
the filtrate was diluted with more dichloromethane and washed 3 times
with 10% sodium hydrogen carbonate solution and then 3 times with water.
The dichloromethane solution was dried (anhydrous sodium sulfate) and
concentrated. The residue was filtered through a neutral alumina
column (120 g) eluted with ethyl acetate. The crude mixture was then
chromatographed on a silica gel column (90 g), eluted from benzene to
ether (10% increments of ether). The components obtained from the
column included androst-4,6-diene-3,17-dione [60] (0.6 g) identical to
starting material, 6a,7a-epoxyandrost-4-ene-3,17-dione [62] (0.23 g),
m.p. 2l2-2l4°C (lit. 7l 2l6-222°C). The IH NMR spectrum included signals
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at 8 0.95 (3H,s C18H), 1.13 (3H,s C19H), 3.51 (2H,s 6SH,7SH), 6.14 (lR,s
C4H). Mass spec. M/e (%): 300 (100), 287 (16), 284 (42),269 (26).
13 C NMR data are presented in Table 1. Other unidentified polar
products were also recovered.
7a-Hydroxyandrost-4-ene-3,17-dione [63]71
0.30 g of 6a,7a-epoxyandrost-4-ene-3,l7-dione was dissolved in
10 mL of 95% ethanol. 0.3 mL of 10% sodium hydrogen carbonate solution
was then added and the mixture cooled to -5°C (ice/sodium chloride).
3.1 g of freshly prepared amalgamated aluminum was added. (The
aluminum amalgam was prepared in the following manner: alumina 5g
(small pellet from Matheson, Coleman and Bell) was added to a solution
of mercuric chloride (1.7 g in 20 mL of water) containing hydrochloric
acid (0.5 mL). The mixture was shaken for 5 minutes and the liquid
decanted. The amalgam was washed with distilled water until the washing
was neutral and used immediately.) After stirring below aoc for 6 hours,
tIc showed the reaction was complete. Chloroform (10 mL) was added and
the mixture filtered. The filtrate was concentrated and residue
chromatographed on silica gel (25 g) eluted from benzene to ethyl
acetate (10% increments of ethyl acetate). After recrystallization
from acetone, 0.21 g of the title compound was obtained, m.p. 227-230°C
(lit. 220-222.SoC72 , 240-245°C71). The IH NMR spectrum included signals
at 80.92 (3H,s, C18H), 1.22 (3H,s C19H) , 4.10 (lH,bs 7S-H), 5.79 (lH,s
C4H). Mass spec. Mle (%): 302 (15), 284 (100), 269 (29). 13 C NMR
data are presented in Table 1.
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The following procedures are a few of the many tried in the attempted
preparation of 7-halo-androst-4-ene-3,,17-dione:
Attempted preparation of androst-4-ene-3,17-dione-7a-p-toluene sulfonate84
20 mg of 7a-hydroxyandrost-4-ene-3,17-dione [63] was added to 2 mL
of dry pyridine. After cooling this mixture to O°C, O.lg of freshly
purified p-toluenesulfonyl chloride was added. The reaction mixture was
then allowed to sit at room temperature for 72 hours at which time tIc
showed the presence of two components. The pyridine was removed under
reduced pressure and chloroform added. After washing with water, S%
aqueous hydrochloric acid and 2% aqueous sodium hydroxide, the
chloroform solution was dried (anhydrous sodium sulfate) and concentrated.
Analysis of the residue by IH NMR and mass spec. showed it to be a
mixture of the starting material and androst-4,6-diene-3,17-dione [60].
When the above reaction was performed below -SoC, no reaction occurred.
AttemEted preEaration of 7a-chloroandrost-4-ene-3,17-dione85
12 mg of 7a-hydroxyandrost-4-ene-3,17-dione was added to 2 mL of
dry chloroform. Thionyl chloride (10 drops in 1 mL of chloroform) was
added with stirring at room temperature. After 30 minutes, tIc showed
two components present, neither of which was the starting material.
After the addition of chloroform (20 mL), the mixture was washed (water),
dried (anhydrous sodium sulfate) and the chloroform evaporated. IH NMR
and mass spectral analysis of the residue showed that only the 6-dehydro
elimination product [60] was present. When thionyl chloride was used as
45
the solvent in the above, reaction, carried out at aoc, a complex
mixture of products was obtained, none of which was the expected
7a-chloride.
Attempted preparation of 7a-methanesulfonyloxyandrost-4-ene-3,17-dione86
0.1 g of 7a-hydroxyandrost-4-ene-3,17-dione was added to 5 mL of
pyridine. 0.18 g of methanesulfonyl chloride was added and the mixture
stirred at room temperature for 5 hours. Ether was added and the mixture
washed with water (4 times), then dried (anhydrous sodium sulfate). The
ether was rotary evaporated and the crude residue subjected to IH NMR
and mass spectral analysis which showed only the 6-dehydro-steroid [60]
was present. When the above reaction was attempted at -20°C for 72 hours,
no reaction occurred.
Attempted preparation of 7a-chloroandrost-4-ene-3,17-dione87
33 mg of sodium chloride was added to 4 mL of the 70% HF/pyridine
,reagent in a polyethylene bottle. 15 mg of 7S-hydroxyandrost-4-ene-
3,17-dione was added to this mixture with stirring at O°C. The reaction
mixture was stirred at room temperature for 29 hours, after which time
the dark mixture was poured into ice water and then neutralized with
saturate.d sodilll1l carbonate solution. The mixture was extracted with
methylene chloride and after drying (anhydrous sodium sulfate), the
methylene chloride was evaporated. TIc showed two components were
present. IH NMR and mass spectral analysis further confirmed that both
starting materials and the 6-dehydro steroid [60] were present, [60]
being the major component.
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Attempted preparation of 7a-bromoandrost-4-ene-3,17-dione88
0.1 g of androst-4,6-diene-3,17-dione in 2 mL of glacial acetic acid
was cooled to 16°C. 1 mL of 48% HBr was added and the mixture stirred in
an icewater bath for 0.5 hours. At this time, tIc showed 2 components
present, however, when methylene chloride was added and the mixture was
allowed to warm to room temperature, only the starting material- was
observed when analysed by tIc and IH NMR spectroscopy. The same results
as those above were obtained when anhydrous hydrochloric acid replaced
hydrobromic acid and THF was used as the solvent.
. 89 90Attempted preparation of 7a-chloroandrost-4-ene-3,17-dlone '
To a stirred solution of 44 mg of N-chlorosuccinimide in 2 mL of
dry THF, was added 73 mg of triphenylphosphine in 2 mL of dry THF. To
this suspension was added 42 mg of 7B-hydroxyandrost-4-ene-3,17-dione.
After stirring at room temperature for 1 hour, the mixture became clear
and tIc indicated the presence of two components. The solvent was then
removed under reduced pressure and chloroform added. The chloroform was
washed (water), dried (anhydrous sodium sulfate) and evaporated. IH NMR
and mass spectral analysis of the crude residue indicated the presence of
at least two steroidal products, none of which was either the starting
material or the expected 7a-chioro steroid. The products were not
further identified.
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Preparation of reagents
2-Chloro-l,1,2-trifluorotriethylamine [50]57,73
The procedure used was that described by Knox et al.S7
2-chloro-l,1,2-trifluoroethylene was bubbled into 40 mL of diethylamine
in a large test tube· maintained between -5°C and -10°C for 8 hours.
The crude product was distilled in vacuo to give 35 g of a colourless
liquid (48% yield). It was necessary to distill off the coloured
impurities before the product was collected. The IH spectrum showed
signals at 6 1.20 (6H,t CH3), 2.95 (4H,q CH2) and 6.27 (lH,d CHClF).
2,3-Dicyanohydroquinone [74]79
Concentrated sulfuric acid (50 mL) in 95% ethanol (200 mL) was added
to a stirred suspension of benzoquinone (40 g) in 95% ethanol (900 mL).
The temperature was kept between 24 and 28°C during the addition of
potassium cyanide (80 g) in water (200 mL) over 45 minutes. The
potassium cyanide solution was added until the light brown mixture turned
dark brown and alkaline to litmus paper. The mixture was just acidified
and the potassium sulfate filtered and washed with hot 95% ethanol
(200mL). The combined filtrate was concentrated under reduced pressure
to about 200 mL without excessive heating.
The residue was cooled on ice and the crystals (black) filtered.
Recrystallization from water with charcoal provided 21 g (68%) of
2,3-dicyanohydroquinone, m.p. 260°C. The IH mIR spectrum showed signals
at 62.31 (2H,b.s OH), 7.02 (2H.,s ArH). Mass spec. 'M/e (%): 160 (100),
132 (27).
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2,3-Dich1oro-5,6-dicyanobenzoquinone (DDQ) [61]80
10 g (0.062 moles) of [74] was added to a solution of water (70 mL)
and concentrated hydrochloric acid (70 mL). The resultant suspension was
treated with 19 g (0.15 moles) of nitric acid (70%) over 45 minutes with
stirring at 35 ± 3°e. After the addition of the nitric acid, the yellow
suspension was stirred for another hour, then filtered and washed with
carbon tetrachloride. After drying in vacuo for 12 hours, 12.0 g of a
bright yellow powder was obtained, m.p. 212-214°C (lit. 212-213°C,82
213-214°C81}. ~ss spec. M/e (%): 230 (57), 228 (100),226 (57),202
(19), 200 (37), 198 (16), 172 (31), 170 (39).
Benzy1ch1orobistriphenylphosphinepa11adium(II) [56]82
0.2 g of tetrakis(tripheny1phosphine)palladium(0) [75] was added
to a Nz-flushed 100 roL round-bottomed flask. 15 mL of dry benzene was
flushed with nitrogen, then added to the flask. To the yellow suspension
was added 0.42 g of distilled benzyl chloride in 1 mL of dry benzene also
flushed with nitrogen. The mixture was stirred at room temperature for
two hours and then the solvent was removed in vacuo. 30 mL of anhydrous
ether was added to the residue and after 2 hours, the pale yellow crystals
were filtered, washed 3 times with 15 mL portions of hexane to give 0.12 g
of the title compound, m.p. 135-13rC (lit. 140-144°C,82 147-151°C83 ). The
lH NMR spectrum showed signals at 0 2.81 (2H,s benzylic H) and 6.71
(38H,m ArH).
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Incubations with Aspergillus niger ATCC 9142 27
Incubations were performed in one liter Erlenmeyer flasks, or a
5 L fermentation vessel, at 28°C. The one liter flasks were shaken at
180-190 rpm on a New Brunswick rotary shaker wlilile the 5 L fermentation
vessel was mechanically stirred and aerated with air sterilized by
passage through a Whatman Gamma 10 filter.
The growth medium contained Czapex Dox nutrient (35 giL) and was
autoclaved at 15 pounds pressure and 120°C for 20 minutes. After cooling,
the flasks were inoculated with spore suspensions obtained by shaking agar
slopes of ~ niger with sterile water. The flasks were incubated under
the conditions mentioned above for 2 days, after which ~he various
substrates listed below were added in 95% ethanol (20 mg/mL). After a
further growth period, the mycelia were separated from the medium by
filtration and both extracted with dichloromethane. The extracts were
dried pver anhydrous sodilllIl sulfate and concentrated.
Pregn-4-ene-3,20-dione [11]
Incubation of 0.8 g of this substrate for control purposes for 4
days provided 0.51 g of crude extract which was chromatographed on a
silica gel column (25 g) by stepwise elution from benzene to ether
(increments of 10% ether) to give pregn-4-ene-3,20-dione [11] (0.20 g);
spectral data identical with the-starting substrate, and 2l-hydroxypregn-
4-ene-3,20-dione I17] (0.21 g) identified by spectral comparison with
authentic material.
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2l-Fluoropregn-4-ene-3,20-dione [47]
Incubation of 0.8 g of this substrate for 5 days provided 0.71 g
of crude extract. The crude extract was chromatographed on silica gel
by stepwise elution from benzene to ether (10% increments of ether).
0.35 g of the starting material was recovered in addition to a small
amount of an unidentified metabolite obtained in an impure form. The
mass spectrum of this metabolite showed a molecular ion at mle = 348
corresponding to the addition of one oxygen atom to the substrate.
Further characterization was not attempted due to the limited quantity
and the impure state of the material.
21-Chloropregn-4-ene-3,20-dione [46]
Incubation of 1.0 g of this substrate for 4 days gave 0.82 g of
crude extract. Thin layer chromatography showed the main component to
be substrate. The crude extract was chromatographed on 40 g of silica
gel by stepwise elution from benzene to ether (10% increments of ether).
The substrate (0.61 g) was the only component isolated from the column.
2l-Bromopregn-4~ene-3,20-dione[48]
Incubation of 1.0 g of this substrate for 4 days provided 0.79 g of
crude extract. TIc showed the major component to be the substrate. The
crude extract was further analysed by IH NMR which showed that the
substrate was the only steroidal material present. Recrystallization of
the crude extract from acetone provided pure 21-bromopregn-4-ene-3,20-
diane.
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21-Methy1pregn-4-ene-3,20-dione [55]
Incubation of 0.16 g of this substrate for 4 days provided 0.12 g
of crude extract. TIc showed the major component to be the starting
substrate. Further analysis by 1H NMR showed only the starting material
was present.
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Incubation with Curvularia lunata NRRL 2380 46
Vegetative cell cultures of ~ lunata were grown in one litre
erlenmeyer flasks consisting of the following components:
perc'ant per litre of water
1.0 10 g
1.0 10 g
0.2 2 g
0.1 1 g
0.05 0.5 g
0.05 0.5 g
0.001 0.01 g
Difco tryptong
sucrose
sodium nitrate
dipotassium hydrogen phosphate
magnesium sulfate heptahydrate
potassium chloride
ferrous ~ulfate heptahydrate
0.25 percent of calcium carbonate was added prior to sterilization at
15 pounds pressure, 120°C for 20 minutes.
Inoculations were made from 4% agar slopes of the fungus and the
one litre flasks containing 180 mL of the medium was incubated at room
temperature on a New Brunswick rotary shaker (180 rpm) for 2 days. The
steroidal substrates listed below were then added in 95% ethanol and the
fermentation continued for various time periods. The mycelia were then
separated from the medium by filtration and both extracted with
dichloromethane. The dichloromethane was then dried (anhydrous sodium
sulfate) and concentrated. The crude residues were subjected to
chromatography as necessary.
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Pregn-4-ene-3,20-dione [1]
Incubation of 0.6 g of this substrate for control purposes for 24
hours provided 0.50 g of crude extract. After chromatographing the crude
extract on silica gel by stepwise elution from benzene to ether
(increments of 10% ether), the following components were identified:
pregn-4-ene-3,20-dione [71] (0.15 g) identical with starting material,
11S-hydroxypregn-4-ene-3,20-dione [58] (0.12 g) identical in all respects
to the chemically prepared material, 14a-hydroxypregn-4-ene-3,20-dione
18c 1[64] (0.10 g), m.p. 184-188°C (lit. 192.5-194°C). The H NMR spectrum
included signals at 0 0.79 (3H,s C18H), 1 0 21 (3H,s C19H) , 2.12 (3H,s
C21H), 5.68 (lH,s C4H). Mass spec. M/e (%): 330 (61), 312 (100), 297
(24), 269 (29), 149 (98). Also isolated was llS,14a-dihydroxypregn-4-ene-
3,20-dione [65] 0.05 g, m.p. 220-22loC (lit. l8d 224-227°C). The IH NMR
spectrum included signals at 0 1.01 (3H,s C18H) , 1.46 (3H,s CI9), 2.12
(3H,s C21H), 4.35 (lH,m llaH), 5.64 (lH,s C4H). Mass spec. M/e (%):
346 (1), 328 (1), 310 (1), 204 (4), 154 (100).
11S-fluoropregn-4-ene-3,20-dione [52]
Incubation of 0.7 g of this substrate for 60 hours gave 0.54 g of a
crude extract. The crude extract was chromatographed on preparative tIc
plates developed with 4% methanol in ether. The following components
were identified: 11S-fluoropregn-4-ene-3,20-dione [61] (0.25 g),
identical to starting substrate, 11S-fluoro-14a-hydroxypregn-4-ene-
3,20-dione [66] (0.12 g), m.p. 193-l95°C. The IH NMR spectrum included
signals at 8 0.89 (3H,d C18H), 1.37 (3H,d C19H), 5.11 (lH,m llaHO,
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5.69 (lH,s C4H). Mass spec. M+ found 348.210; calculated for C21H2903F
348.210; M/e (%): 348 (6), 330 (36), 310 (36), 287 (43), 123 (100).
Rf values: 0.77 (benzene:ethyl acetate:acetone--3:3.5:3.5), 0.81
(benzene:acetone--3:7), 0.51 (acetone:hexane--8:2). Also identified was
11S-fluoro-14a,2l-dihydroxypregn-4-ene-3,20-dione [67] (0.05 g) rn.p.
l75-178°C. The IH NMR spectrum included signals at 0 0.92 (3H,d C18H),
1.37 (3H,d C19H), 4.20 (2R,d C2lH), 5.08 (lH,rn lIaR), 5.70 lH,d C4H).
Mass spec. M+ found 364.206; calculated for C21H2904F 364.205; M/e (%):
364 (1), 346 (2), 333 (27), 315 (100), 295 (9). Rf values: 0.70
(benzene:acetone--3:7), 0.59 (benzene:ethylacetate:acetone 3:3.5:3.5),
0.29 (acetone:hexane--8:2).
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Incubations with Rhizopus arr~izus ATCC 11145 76
Rhizopus sto1onifer ATCC622]q,75
These fungi were grown under the same conditions. The medium
consisted of glucose (50 g), peptone (20 g) and corn steep liquor (3 ml)
(Grand Island Biochemical Co.), per litre of distilled water. Incubations
were performed in one litre Erlenmeyer flasks each containing 150 mL of
the medium. The flasks were sterilized at 15 pounds pressure, 120°C for
20 minutes. After cooling, the flasks were inoculated with spore
suspensions obtained by shaking agar slopes of the fungus with sterile
water. The flasks were then incubated on a New Brunswick rotary shaker
at room temperature for 60 hours after which time the mycelia were
separated from the medium by filtration. The mycelia were washed with
distilled water, macerated in a Waring blender with distilled water and
aliquots re-suspended in distilled water (150 mL).
The steroidal substrates were then added in 95% ethanol (30 mg/ml)
and incubation continued for various time periods under the same conditions
outlined above. The mycelium and the water were then separated and both
extracted with dichloromethane. The solvent was dried with anhydrous
sodium sulfate and removed under reduced pressure. The crude residue
was then subjected to chromatography when required.
11S-Fluoropregn-4-ene-3,20-dione
Incubation of 0.92 g of this substrate with R. stolonifer for 36
hours provided 1.61 g of crude extract. TIc showed the medial fraction
contained mainly one component with a lower Rf value than the starting
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material, while the mycelial fraction contained the unmetabolized
substrate. Recrystallization of the medial extract provided 0.30 g of
pregn-4-ene-3,11,20-trione [57], identical with both commercial and
laboratory prepared material. Recrystallization of the mycelial extract
gave 0.5 g of the starting substrate.
IlS-Hydroxypregn-4-ene-3,20-dione
Incubation of 0.35 g of this substrate with R. stolonifer for 35
hours provided 0.4 g of crude extract. TIc showed only one component.
Recrystallization of the crude extract from methanol gave 0.30 g of pure
pregn-4-ene-3,11,20-trione [57] also identical with authentic sample.
And~ost-4-ene-3,17-dione
This incubation was performed to obtain 7S-hydroxandrost-4-ene-
3,17-dione [70]. Incubation of 4.2 g of this substrate with R. stolonifer
for 4 days provided 5.0 g of crude extract. The extract was
chromatographed on silica gel by eluting with 70% ethyl acetate in
benzene. The following components were identified: androst-4-ene-
3,17-dione [10] (0.92 g), identical to the starting material,
6S-hydroxyandrost-4-ene-3,17-dione [33] (1.51 g), m.p. l89-l91°C (lit. 29
191-l94°C). The I H NMR spectrum included signals at 0 0.95 (3H,s C18H),
1.41 (3H,s C19H), 4.39 (lH,bs 6aH), 5.81 (lH,sC4H). Also identified was
lla-hydroxyandrost-4-ene-3,17-dione [69] (0.21 g), m.p. 220-223°C
29(lit. 225-22 7°C) • The I H NMR spectrum included signals at 0 0.96 (3H, s
C18H) , 1.35 (3H,s C19R), 4.00 (lH,m 11SH) , 5.74 (lR,s C4H). Also
identified was 7f3-hydroxyandrost-4-ene-3,17-dione [70] (0.32 g), m.p.
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2l8-220°C (lit. 75 220.5-222.5°C). The IH NMR spectrum included signals at
8 0.94 (3H,s C18H), 1.24 (3H,s C19H), 3.52 (lH,m 7aR) , 5.78 (lH,s C4H).
Mass Spec. M/e (%): 302 (100), 287 (16), 284 (42), 269 (3l)~ 13C NMR
data are presented in Table 1.
Androst-4,6-diene-3,17-dione
Incubation of 1.7 g of this substrate for control purposes with
R. arrhizus for 21 hours provided 1.8 g of crude extract. TIc showed the
extract to be a complex mixture of products. Attempts were made to
separate the individual components using preparative tIc plates (silica
gel). The solvent mixtures employed in the development of the plates
included 25% acetone/hexane, 10% acetone/benzene and 5% methanol/benzene.
Only three components were isolated in a pure state. They included
6a,7a-epoxyandrost-4-ene-3,17-dione [62] (0.15 g) identical with
chemically prepared material, 6f3,7f3.-epoxyandrost-4-ene-3,17-dione [71]
(0.23 g), m.p. 2l0-2l3°C. The IH NMR spectrum included signals at 0 0.96
(3H,s C18H) , 1.24 (3H,s C19H), 3.45 (2H,s 6aH,7aH), 6.17 (lH,s C4H).
Mass spec.M+ found 300.175; calculated for C19H2403 300.172. M/e(%):
300 (9), 285 (9), 185 ,(48), 149 (56), 71 (100). Rf values: 0'.80
(benzene:ethyl acetate:acetone 3:3.5:3.5),0.81 (benzene:acetone 3:7),
0.61 (acetone:hexane 8:2). 13 C NMR data are presented in Table 1.
and l7f3-hydroxyandrost-4,6-diene-3,16-dione [72] (0.16 g), m.p. l78-l80°C.
The IH NMR spectrum included signals at 0 0.83 (3H,s C18), 1.15 (3R,s C19),
3.81 (lH,s l7aH) , 5.71 (lR,s C4H), 6.08 (2H,m C6H,C7H). Mass spec. lrr
found 300.162, calculated for C19H2403 300.172, M/e (%): 300 (16),
282 (8), 267 (5), 228 (23), 91 (100). 13 C NMR data are presented in
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Table 1. Analysis: (found C 75.00%, H 8.04%; C19H2403 requires C 75.96%,
H 8.06%).
7a-Hydroxyandrost-4-ene-3,17-dione [63]
Incubation of 0.2 g of this substrate for 50 hours with R. arrhizus
provided 0.25 g of crude extract. TIc showed only the starting material
was present. Recrystallization of the crude residue from acetone gave
0.18 go of the substrate.
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Table 1. 13C chemical shifts of steroidal products (values in ppm
relative to TMS = 0, solvent: CDC13)·
c-l! [46] [47] [48] [49] [51] [52] [53]
1 35.7 35.7 35.7 37.3 35.5 35.3 35.8
2 33.9 33.9 33.9 34.2 33.8 33.7 33.9
3 199.2 199.3 199.2 199.1 197.6 198.9 199.9
4 124.1 124.1 124.1 124.1 124.9 123.1 124.0
5 170.6 170.6 170.5 169.5 166.8 170.6 171.3
6 32.7 32.7 32.7 32.8 29.8 32.1 32.9
7 31.8 31.9 31.8 32.1 27.6 31.7 32.0
8 35.6 35.6 35.7 31.1 35.5 31.1 35.8
9 53.6 53.6 53.6 145.2 87.7, 89.1 55.6, 57.0 53.7
10 38.5 38.4 38.5 41.0 45.7 38.9 38.6
11 20.9 20.9 21.0 118.4 86.4, 98.5 83.9, 95.6 20.9
12 38.5 38.5 38.5 40.7 39.3, 40.1 43.8, 45.1 37.9
13 44.6 44.9 44.7 42.3 42.5 42.6, 42.7 44.0
14 56.0 56.2 56.0 52.9 50.6 56.6 55.1
15 24.4 24.5 24.4 26.0 23.5 24.2 24.4
16 23.5 22.5 23.7 25.4 22.6 22.7 23.4
17 59.9 57.7 60.2 63.4 63.1 63.6 55.5
18 13.5 13.6 13.6 13.0 14.9, 15.4 14.7, 15.2 13.3
19 17.3 17.4 17.4 23.0 22.2, 23.1 20.1, 20.8 17.4
20 202.1 206.0, 207.2 201.8 209.0 208.2 208.4 179.8
21 49.4 79.2, 91.6 35.7 33.8 33.8 32.1
22
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Table 1. (continued)
c-fI [55] [60] [62] [63] [70] [71] [72]
1 35.6 33.9 34.0 35.,4 33.9 34.0 33.6
2 33.9 33.9 33.9 33.9 31.3 34.9 33.8
3 199.5 199.4 199.2 199.3 199.4 198.0 199.5
4 124.0 124.3 131.5 127.0 124.9 129.7 124.3
5 171.1 162.9 161.8 168.0 167.4 162.1 162.9
6 32.8 128.8 52.6 39.4 38.3 55.6 128.9
7 31.9 138.5 53.5 67.0 74.2 57.7 138.8
8 35.6 37.1 35.6 41.1 36.0 36.1 36.1
9 53.7 48.8 46.8 45.3 50.6 51.6 46.8
10. 38.7 36.1 34.3 38.6 38.1 36.6 35.1
11 21.0 20.1 19.2 20.2 20.4 20.5 20.1
12 38.6 31.3 31.1 31.0 31.2 31.0 36.3
13 44.1 48.3 47.8 37.3 48.1 48.3 43.3
14 56.1 50.8 40.9 45.6 50.8 47.9 50.7
15 24.4 21.5 21.4 21.3 24.9 21.5 36.1
16 23.1 35.6 35.6 35.8 35.6 35.5 216.1
17 62.5 219.5 219.5 220.8 221.0 219.1 85.9
18 13.5 13.7 13.7 13.5 13.9 13.7 11.3
19 17.4 17.3 17.3 17.0 17.4 16.8 16.3
20 211.9
21 33.9
22 7.7
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RESULTS A1ID DISCUSSION
Preparation of steroidal substrates
In this study, attempts were made to halogenate three positions of
the steroid nucleus, namely at carbon 21, 11 and 7. Due to steric
difficulties and the different reactivity of each position, it was
necessary to implement different synthetic strategies in each case. In
all three cases, the steroid skeleton possessed the /:).4-3-keto function.
The products from the reactions were identified by comparison of their
physical constants with those in the literature and by spectroscopic
examination. 1 H NMR, 13C N11R and mass spectrometry were especially
useful for fast identification of the various products.
The procedure followed in the preparation of the 2l-halogenated
steroids was quite straightforward (Scheme 1). Yields were moderate
(in the case of 2l-fluoropregn-4-ene-3,20-dione [47]) to good for the
21-chloro and bromo analogues. During the preparation of [47], the crown
ether [73] was added to chelate potassium ions, thus providing a greater
concentration of "free" fluoride ions to participate in the nucleophilic
substitution. The use of the crown ether significantly improved the rate
of formation and the yield of the 21-fluorinated product [47] .49
During the preparation of 2l-methanesulfonyloxypregn-4-ene-3,20-
dione [45], it was observed that when the temperature of the reaction
was allowed to rise above QOC, two products were obtained, whereas when
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Scheme I. Preparation of 21-substituted
pregn-4-ene-3,20-diones
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the temperature was kept below O°C, only [45] was isolated, which was
identical to one of the two products obtained above. Analysis of the
second product proved it to be 2l-chloropregn-4-ene-3,20-dione [46].
When the reaction was repeated at ambient temperature, only [46] was
obtained in high yield. The chlorinated product most likely resulted
from the internal displacement of themesylate group by the chloride ion
(Fig. 9).
The procedure followed in the preparation of 2l-methylpregn-4-ene-
3 20 d · [55]· · · 1 66 b h h' kId·, - lone lS not orlglna, ut to t e aut or snow e ge, no
previous reports have been made applying this relatively new procedure
to the preparation of steroidal ketones. As outlined in the experimental
section, the final reaction in the preparation of [55] involved the
reaction of tetraethyltin and the acid chloride [54] in the presence of
the catalyst [56]. At first glance, this reaction appears to be a simple
transfer of ethyl groups and chloride ions to the steroid and the tin
compound respectively. However, a potentially more complex mechanism
involving the catalyst [56] has been suggested (Fig. 10).66
The prdposedmechanism suggests that the active catalyst
bis (triphenylphosphine) palladium (0) [75] is generated from I56] by a
series of double exchanges and reductive eliminations. The acid chloride
[54] then oxidatively adds to the active catalyst I75] generating a
palladium (II) complex which undergoes metathesis with the tin compound
and reductively eliminates the product ketone.
The yield of 2l-methylpregn-4-ene-3,20-dione [55] was moderate at
40%, but the conditions for optimum yield were not fully investigated.
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Figure 9. Suggested mechanism for the preparation
of 21-chloro-pregn-4-ene-3,20-dione
o
H
l17J
©
H
Cl
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Figure 10. Suggested mechanism for the preparation
of 21-methyl-pregn-4-ene-3,20-dione
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From preliminary studies, the rate of the reaction appears to be
temperature dependent, since at 80°C, the reaction was complete in about
50 percent of the time required when performed at 65°C. The catalyst
appears to be unstable over extended periods of time since the desired
product was not obtained when catalyst prepared two weeks earlier was
used. The procedure is relatively simple when compared to previously
reported procedures for the preparation 6f compounds similar in structure
to the one under consideration. The possibility exists that this
procedure could be of value in further lengthening of the progesterone
side chain.
The preparation of 11S-fluoropregn-4-ene-3,20-dione r52] was also
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accomplished through the use of literature procedures. '
other procedures have been described~O,62 "for the preparation of
lIS-fluorinated steroids, all attempts to repeat them were unsuccessful.
The successful procedure involved the trans addition of bromine
and fluorine to pregn-4,9(ll)-diene-3,20-dione [49] using the reagents,
N-bromosuccinimide and 70% HF/pyridine mixture. The use of the 70%
HE/pyridine reagent eliminated obvious difficulties associated with the
use of anhydrous hydrofluoric acid. In the reaction, the conjugate
acid of N-bromosuccinimide [77] serves as a source of electrophilic
bromine which reacts with the olefin from the less hindered a-side to
form the bridged ion [78]. This ion in turn reacts stereospecifically
with fluoride to form the trans bromofluoro- compound [51] (Scheme 11).59,92
Pregn-4,9(11)-dione-3,20-dione [49) was prepared in high yield from
lla-hydroxypregn-4-ene-3,20-dione [18] using 2-chloro-l,1,2-trifluoro-
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Scheme II. Preparation of 11S-fluoropregn-4-ene-3,20-dione
[49)
[ 18]
Pyr
HF
[ 51)
Sn(n-But)3H
r78 J
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triethylamine [50]. Our first intention was to use [50] as a fluorinating
5062
reagent since this reagent was reported ' to react with [18] to give
the IIS-fluoro analogues [52]. In all attempts, no fluorinated steroids
were isolated even when the reaction was performed below -50°C. The
mechanism involved in the fluorination of steroidal alcohols by [50] is
not fully understood, but is believed to be quite complex, since the
types of products obtained depends not only on the conditions of the
reaction, but also on the position of the hydroxy group in the steroid
skeleton. The reaction of [50] with lla-hydroxypregn-4-ene-3,20-dione
[18] appears to involve very unstable intermediates which readily
eliminate, due to the high degree of steric hindrance at carbon-II
62(Scheme III).
The bromine atom was then reductively eliminated from 9a-bromo-
IlS-fluoropregn-4-ene-3,17-dione[51] using tri-n-butyltin hydride to give
11S-fluoropregn-4-ene-3,20-dione [52] (Scheme II). The tributyltin
hydride reagent is reported to reduce tertiary halides leaving primary
and secondary halides unaffected. 74
An interesting aspect of both [51] and [52] is the long range
coupling of the fluorine atom to carbons and protons 4 and 5 bonds away
respectively. There appears to exist some controversy over whether the
coupling occurs through space or through the bonds adjoining the
1 · 55,93,94nuc e1.
93In an earlier study electronegative groups were placed at various
positions to observe their effect on the magnitude of the coupling
constants (J) between the 6S-fluorine and the 18- and 19-methy1 protons
of several steroids. It was reported that the introduction of a chlorine
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Scheme III. Mechanism for the dehydration of
lla-hydroxypregn-4-ene-3,20-dione
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atom at the 9a.-position of the II-fluorinated steroid [79] did not
significantly affect the magnitude of J18H ,11SF' whereas there was a
substantial increase in the J l9H,llSF value. This finding was used to
vaguely support a through space mechanism based on the assumption that
the 9a.-chlorine causes perturbation of the 19-methyl proton orbitals,
but is too distant from the 18 protons to bring about comparable changes.
In the present study, introduction of a 9o.-bromine in [51] appears
to have no significant effect on the magnitude of J l9H ,llSF or J l8H ,llSF
(see Table 2). Our results would appear to be more significant since in
the earlier study, the J values were calculated from structurally
different compounds, [79] and [80].
Further insights into the mechanism of these long range couplings
were gained through examination of the 13 C NMR spectra of [51] and [52].
Comparison of the J13C ,11SF values of the nuclei in the chain from both
C18 and Cl9 to 11SF in [51] and [52] shows that the introduction of the
bromine atom at the 90. position again does not significantly affect
the magnitude of either J l8CP,llSF or J l9C13,llSF although the bromine
atom appears to have distorted the Band C rings in such a manner that
there is a slight increase in the magnitude of J l9C13,llSF and a decrease
in the magnitude of J l2C13,llSF{see Table 3). The fact that the
J 13 11. decreases sharply with increasing distance, and thenC -SF
increases for J l8C13,llSF and J l9C13,llSF is strong evidence supporting
a through space coupling mechanism.
Attempts were made to prepare the II-chlorinated analogue using the
procedure just outlined above. Thus the trans addition of bromine and
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[52]
[79]
[80]
Table 2.
Table 3.
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J and J18H,11SF 19H,11SF values (Hz) for [51] and [52].
[51] [52]
J18H ,11SF 2.93 2.74
J19H ,11BF 4.03 4.03
JC13,11SF values (Hz) for [51] and [52].
Carbon 11 [51] [52]
19 13.77 9.18
10 0.0 0.0
9 20.20 22.20
11 142.18 176.13
12 20.20 19.19
13 0.0 1.84
18 7.34 6.42
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chlorine to pregn-4,9(11)-diene-3,20-dione [49] using N-bromosuccinimide
and anhydrous hydrochloric acid furnished the unstable 9a-bromo-
11S-chloropregn-4-ene-3,20-dione [80]. Subsequent attempts to
reductively eliminate the bromine atom again using the tin hydride
reagent were unsuccessful. A recent report has claimed the preparation
of 11S-chloropregn-4-ene-3,20-dione [81] in 4% yield by the treatment
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of lla-hydroxypregn-4-ene-3,20-dione [18] with [50] and lithium chloride.
Attempts to halogenate the third position (carbon 7) of the steroid
skeleton proved much more difficult than first anticipated. Numerous
approaches were tried unsuccessfully to displace both the 7a and 7S
hydroxy groups of androst-4-ene-3,17~dione [10] using a variety of
reagents. Attempts to prepare sulfonate esters which could act as good
leaving groups were also unsuccessful.
The difficulties encountered in the preparation of the ~4-3-keto­
7-halogenated steroids may be attributed to the instability of these
analogues or alternatively to the stability of the ~4,6-3-keto function.
In many instances, the product isolated after attempted nucleophilic
displacement of the 7-hydroxy group or from attempts to prepare sulfonate
esters was the 6-dehydro-steroid [60].
Since both the 7a and 7S hydroxy steroids are stable, it is
reasonable to postulate that in some instances, nucleophilic displacement
or sulfonate ester formation did occur, but these products quickly
decomposed to [60] through the elimination of the appropriate hydrohalic
acid or sulfonic acid (Fig. 11).
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Figure 11. Proposed mechanism for the elimination
of 7a substituents from ~4-3-keto steroids
[60]
+ HX
x =
77
T d h d f h - d d 88 b· d h· howar s teen 0 t 1S stu y, a patente paper was 0 ta1ne W 1C
reported procedures for the preparation of ~4-3-keto-7-halogenated
steroids. These compounds were reported to be unstable at room
temperature since they spontaneously eliminated hydrohalic acid giving
the ~4,6-3-keto steroid. This elimination is quite rapid in a basic
environment.
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Incubations
Table 4 shows the various steroids used as substrates and the
results of incubating them with the four fungi listed. The new as well
as known compounds were identified mainly by spectroscopic examination.
Among the spectrometric methods for locating oxygenated substituents
(particularly hydroxyl groups) in the steroid nucleus was examination of
the IH-NMR signal of the 18 and 19 protons. The large volume of reference
data9S ,96 and t'he · h b· · th ·dassumptlon t at su stltuents present ln e sterol
nucleus contribute a fairly constant increment to the chemical shift of
the 18 and 19 protons and that these increments are additive provided
the basis for using this technique.
The position and form of the CHOR resonance also provided valuable
information regarding the position of hydroxylation and some times about
the configuration of the hydroxyl group. Mass spectrometry was generally
employed to confirm the nuinb,er of oxygens introduced into the substrates
by a particular fungus.
Incubation with Aspergillus niger ATCC 9142
It has been reported that the replacement of a C-2l hydrogen of
pregn-4-ene-3,20-dione [11] by a fluorine atom increases the
progestational activity of this new analogue by a factor of 2-4 over
[1I] .16 The same substitution with chlorine, bromine or a methyl group
: 67 97 98
also gave progestational activity, but much lower than [11]. ' ,
The suggestion has been made that halogen substitution into the
steroid nucleus sometimes retards biochemical degradation of these
Table Results from incubation of the substrates listed with the four fungi listed.*
Substra.te · Fungus
Pregn-4-ene-3,20-dione Aspergillus niger ATCC 9142
21-Fluoropregn-4-ene-3,20-dione Aspergillus niger ATCC 9142
21-Chloropregn-4-ene-3,20-dione Aspergillus niger ATCC 9142
2l-Bromopregn-4-ene-3,20-dione Aspergillus niger ATCC 9142
21-Xethylpregn-4-ene-3,20-dione Aspergillus niger ATCC 9142
Substrate Products (%)
recovered
(%)
25 21-hydroxypregn-4-ene-3,20-dione (25)
44 none identified
60 none identified
62 none identified
80 none identified
Pregn-4-ene-3,20-dione Curvularia lunata NRRL 2380 30 11S-hydroxypregn-4-ene-3,20-dione (24)
14a-hydroxypregn-4-ene-3,20-dione (20)
11S,14u-dihydroxypregn-4-ene-3,20-dione (10) """-J
'-0
11S-Fluoropregn-4-ene-3,20-dione
11S-F1uoropregn-4-ene-3,20-dione
I1B-Hydroxypregn-4-ene-
3,20-dione
Artdrost-4-ene-3,17-dione
Androst-4,6-diene-3,17-dione
7~-Hydroxyandrost-4-ene­
3,17-dione
Gurvularia lunata NRRL 2380
Rhizopus stolonifer
t ATCC 6227b
Rhizopus stolonifer
ATGC 6227b
~~izopus stolonifer
ATCC 6227b
Rhizopus arrhizus ATCC 11145
Rhizopus arrhizus ATCC 11145
29
54
o
21
10
90
I1B-fluoro-14a-hydroxypregn-4-ene-3,20-dione (17)
11B-fluoro-14a,21-dihydroxypregn-4-ene-3,20-dione (7)
Pregn-4-ene-3,11,20-trione (33)
Pregn-4-ene-3,11,20-trione (B5)
6S-hydroxyandrost-4-ene~3,17-dione(36)
7S-hydroxyandrost-4-ene-3,17-dione (8)
11a.-hydroxyandrost-4-ene-3,17-dione (5)
6S,7B-epoxyandrost-4-ene-3,17-dione (14)
6a,7a-epaxyandrost-4-ene-3,17-dione (8)
17S-hydroxyandrost-4,6-diene-3,16-dione (9)
none identified
* For· conditions used, see experimental sectionQ
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analogues and thus increases the duration of the physiological effects.
It was therefore of interest to observe the effect halogen substitution
at the C-21 position had on hydroxylation at that position using the
27 99fungus Aspergillus niger, a known C-21-hydroxylator.' The results
from the various incubations are listed in Table 4.
The incubation of 21-fluoropregn-4-ene-3,20-dione [47] with ~ niger
furnished mostly unreacted substrate, but also a small quantity of an
unidentified product having a molecular weight of 348 (determined by mass
spectrometry). This product which is 16 mass units heavier than the
substrate suggested that hydroxylation had occurred at a site other than
the C-2l position. This is assumed since, if hydroxylation had occurred
at the 21-position, the resulting geminal halohydrin would be expected to
be unstable and not amenable to isolation.
The incubation of the 21-chloro- [46] and 2l-bromo [48] analogues
furnished only unreacted substrates. Only about 60 percent of the
substrate was recovered in each case. This low recovery of substrate may
be attributed to difficulties encountered during the extraction of the
mycelia. Alternatively, the low recovery could also stem from initial
_. 100 1019a-hydroxylation since this process 1S known ' to be important in
microbiological degradation of steroids. The incubation of 2l-methyl-
pregn-4-ene-3,20-dione [55] gave starting material largely unchanged.
The results obtained above are consistent with previous studies
which have shown that the presence of an halogen at a 'favoured site of
h d 1 - 11 bl k h d 1 - a·t that sl-te. 47 ,48yroxy atl0n genera y •. oc sy roxy atlon .
Obviously, the C21-methyl group has the same effect. In previous studies,
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the halogens were located at rigid positions while in the case of the
21-halogenated substrates, the methyl hydrogens have more freedom of
rotation and it was expected that the presence of the halogens at the
less rigid position would have less effect on hydroxylation. Therefore,
it appears that the three hydrogens at C-2l are essential for C2l-
hydroxylation to proceed using the fungus ~ niger.
Incubation with Curvularia lunata and Rhizopus stolonifer
Curvularia lunata is known to hydroxylate the steroid nucleus at
several positions, a favoured one being the lIB-position of C-21 steroids
having the ~4-3-keto function. In contrast, ~ stolonifer hydroxylates
the same steroids predominantly at the lla-position. When pregn-4-ene-
3,20-dione was incubated with ~ lunata, three products were identified.
They included the llS- and 14a- monohydroxylated, and 11S,14a-
dihydroxylated products. The incubation of the same substrate with
R. sto1onifer is reported to provide only the lla-hydroxylated product.
It was of interest to compare the effects of a fluorine atom at a
favoured site of hydroxylation (in case of ~ lunata) and the effects the
fluorine atom. at a position gemina1 to that favoured for hydroxylation
(in case of R. stolonifer) had on the metabolism of such a steroid.
The incubation of 11S-fluoropregn-4-ene-3,20-dione [52] with both
fungi provide significantly different products (Table 4). Whereas
~ lunata provided products hydr~xylated at sites remote from the fluorine
atom, R•. stolonife~ provided only the keto product [57] which in all
probability resulted from initial hydroxylation at the lla-position of
[52] followed by loss of HF from the unstable halohydrin. In both cases
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Figure 12. Hydroxylation of lIS-substituted
pregn-4-ene-3,20-dione by Rhizopus stolonifer
[52]= X = F
[58): X =-01-1
-'1-1 X
[57J
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the presence of the fluorine slows the apparent rate of hydroxylation
of [52].
The incubation of l1S-hydroxypregn-4-ene-3,20-dione [58] with
~ stolonifer also provided the trione [57]. However, in this case the
conversion was quite fast. Within 36 hours [58] was completely converted
to [57]. Again it is reasonable to postulate that the II-keto group
resulted from the loss of water after initial lla-hydroxylation of the
substrate (see Fig. 12). However, it is also possible that the lIS-hydroxy
group was simply oxidized by an alcohol dehydrogenase. The results
obtained with the previous incubation with [52] suggest that the fonner
pathway is more plausible.
The products obtained from the incubation of [52] with ~ lunata
included the l4a-monohydroxylated [66] and l4a,2l-dihydroxylated [67]
metabolites. The fluorine atom appears to have directed hydroxylation
from the lIS-position to the 2l-position. C-21-hydroxylation by this
strain of C. lunata has not been reported previously.
Fluorine atoms at sites other than those favoured for hydroxylation
also have an effect on the positions 'in the substrate that are
hydroxylated. 102In one report, the introduction of a fluorine at the
6a position of 2l-hydroxy-16a-methy1pregn-4-ene-3,20-dione [83] provided
products monohydroxylated at the get, lIS and 14a positions whereas the
non-fluorinated substrate [82] gave products monohydroxylated at the
7a, lIS and l4a positions when incubated with C. lunata. Obviously, the
fluorine atom at a site vicinal to one favoured for hydroxylation also
blocks hydroxylation at that site.
o[66J
OH
01-l
[82]
Oli
--CH3
I
I
F
[83J
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Therefore while with ~ lunata, the site of hydroxylation depends on
the positions of the substituents in the substrate, ~ stolonifer shows
a predilection for hydroxylation at the lla-position. The present
findings are consistent with earlier studies with saturated steroids
which have shown some fungi to be site specific and others to be
b · d· d 36-38SU.stltuent lrecte.
At present it is not clear whether a single hydroxylase or a general
hydroxylase system is at work in the production of the many different
products that are obtained depending on the structure of the substrate
in the case of ~ lunata and many other fungi. That the enzymes
responsible for hydroxylation of many positions of the steroid nucleus
are inducible has led at least one investigatorl03 to suggest that a
generalized hydroxylase system is at work during the hydroxylation of
19-norsteroids by ~ lunata. It is clear however that ~ lunata, unlike
!::.:.... niger possesses an abundance of hydroxylases whether in a complex or
acting independently that are able to hydroxylate the various positions
of the steroid skeleton.
Incubation with Rhizopus arrhizus
This fungus is well documented as a 6B-hydroxylator of steroids
having the ~4-3-keto function. . . 28,32In preVlOUS studles in this
laboratory, strong evidence was obtained showing the participation of
an enolic intermediate during 6S-hydroxylation of androst-4-ene-3,17-dione
[10] by ~ arrhizus (see Fig. 4). It was therefore postulated that if an
enzyme was involved in the enol formation during 6B-hydroxylation, then
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Figure 13. Mechanism involved in the formation of the proposed
"suicide" substrate.
-x~
Enzyme
87
by the placement of a "good" leaving group at the 7a-position of [10], an
intermediate, 6-dehydro steroid may result which the fungus cannot
further metabolize. This so-called "suicide" substrate, if subsequently
isolated, would provide further evidence supporting an enolic intermediate
during 6S-hydroxylation.
A 7a substituent would be expected to eliminate faster than a
7S substituent since during 6S hydroxylation, the enolic intermediate
results from the loss of the 68 axial proton. The 6S-proton is trans
diaxial to a 7a substituent, which thus has the correct stereochemistry
for elimination as shown in Figure 13.
The compounds 7a-chloro- and 7a-bromoandrost-4-ene-3,17-dione were
postulated as having the required properties to test the above hypothesis.
Unfortunately, all attempts to prepare them were unsuccessful, most likely
due to their instability as previously mentioned.
Although all attempts to prepare the 7a-halosteroids failed, the
would be "suicide" substrate androst-4,6-diene-3,17-dione [60] was
fermented with ~ arrhizus for control purposes. The products obtained
were quite unexpected. They included both 6S,78- and 6a,7a-epoxyandrost-
4-ene-3,17-dione ([62] and [71]), l7S-hydroxyandrost-4,6-diene-3,16-dione
[72] plus at least two other unidentified products which were quite
difficult to separate.
It is well documented, and was mentioned in the introduction, that
the introduction of a double bond at Gn of a substrate (where Gn was the
favoured site of hydroxylation) would result in epoxidation of the
substrate at Gn by the fungus only if the epoxideformed was axial. In
this case, both the axial and the equatorial epoxides were obtained.
88
[62J
[71 J
[72)
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It is therefore apparent that during the oxidation the enzyme is
able to approach from either the ~ or S face of the substrate to provide
both the 6a,7a- and 6B,7B-epoxides. Thus, the isolation of [62] and [71]
appears to be consistent with earlier findings that 6B-hydroxylation of
~4-3-keto steroids by ~ arrhizus is stereoelectronically controlled by
the substrate and that the enzyme(s) involved are neither stereo- nor
· · f. ·28~ 32reglospecl lC.
The earlier observations that the products [85], [86] and [87] are
produced concurrently by ~ arrhizus from [84] and also that [85], [86]
and [87] are produced by peracid oxidation of [88] and [89] and that the
incubation of the B-norsteroid [90] with ~ arrhizus provided mostly the
a.-epoxide [91]104 does not support a mechanism wherein the regio- and
stereospecificity of hydroxylation is determined solely by the three-
dimensional relationship between the substrate and the enzyme's active
site, although such a mechanism appears to be operative at saturated
carbons remote from a keto group.37,105 Structures similar to [88] and
[89] are believed to be intermediates during enzymic oxidation of [84] to
give [85], [86] and [87] by ~ arrhizus. 76
It is unlikely that an enolic intermediate is involved during the
epoxidation at the C6-C7 bond. It is therefore possible that the enzyme
is unable to differentiate between the structures [92] and [60].
The third identified metabolite, l7B-hydroxy-4,6-diene-3,16-dione
[72] is postulated as arising from 16 hydroxylation of the substrate [60]
followed by rearrangement to give the more stable l7B-hydroxy-16-keto
function (Fig. 14). The identity of this metabolite was ascertained by
[ 85]
H
90
H
[ 84)
H
OH
[ 86]
H
I
I
OH
[ 87]
EtO
( 88]
EtO
[ 89]
HO
[ 90)
140
( 91J
--0
(92)
91
o
[60)
Figure 14. Rearrangement of 16S-hydroxyandrost-4,6-diene-3,17-dione
to 17S-hydroxyandrost-4,6-diene-3,16-dione
[94]
OH
o
01-1
H
[ 72]
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examination of t·he I H NMR and 13 C NMR spectra. The 13C NMR spectrum was
especially informative since it indicated that the hydroxy group was
located at C-17 and that the ~4,6-3-dienone function remained unaffected.
That the carbonyl group was a to the l7-hydroxy group was supported by
h b· - f _. d 1- 106 Th hteo servatlon 0 a posltlve re tetrazo lUffi test. at t e mass
spectrum showed a molecular ion at 300 (16 mass units heavier than the
substrate) confirmed that [72] was a monohydroxylated metabolite.
There is a precedent for the rearrangement just mentioned above since
Dodson and Mizubal07 isolated l7B-hydroxyandrost-4-ene-3,17-dione [95]
from incubation of androst-4-ene-3,17-dione [10] with Corticum centrifugum.
108In another study [95] was also isolated when either [96] or [10] was
fermenfed with~ niger.
The rearrangement of [94] to [72] is supported by the report that
treatment of [97] with dilute sulfuric acid in methanol at room
temperature furnished [95].78
It is not possible to determine unambiguously whether the l6a. or
16B hydrogen is lost on oxidation, but since it was reported that
16S-acetoxy-17-oxo steroids were hydrolysed to the 16-oxo-17-hydroxy
steroids whereas l6a-acetoxy-17-oxo'·'steroids gave only l6a.-hydroxy-
17-oxo steroid, it is assumed that [72] resulted from l6S-hydroxylation
of [60] .77,78
The fermentation of [10] with ~ arrhizus furnished 6S- and lla-
monohydroxy products. Therefore it is rather surprising that the
introduction of a second double bond would result in the complex mixture
oHO
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[95]
[96J
[97J
0\-\
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of products obtained in the latter case. While these results are
. 33 45
surprising, previous stud1es' have shown that the introduction of
unsaturation in other substrates also had dramatic effect on the types
of products obtained. This phenomenon is well-illustrated by comparison
of the products obtained from fermentation of 3S-hydroxypregnan-20-one
[98] and 3S-hydroxypregn-16-ene-20-one [99] (see Table 5). The
differences here are attributed to the allylic nature of the 15 position
33
than to the restricted rotation of the 17-acetyl group.
The suggestion has been made that the different products obtained
before and after introduction of unsaturation could be the result of
increased rigidity and distortion of the substrate. In the present study
molecular models have shown that the introduction of a double bond at the
C6-C7 position of [10] increases the planarity of the AB rings, which
may in part account for the epoxidation from both the a- and S-face.
It is therefore apparent that the introduction of unsaturation
affects the metabolic disposition of the substrate through as yet obscure
and complex means.
In summary then, 2l-halogenated and 2l-methyl' steroids are not
metabolized to any significant extent by the fungus Aspergillus niger.
The placement of a fluorine atom at a favoured site of hydroxylation
blocks hydroxylation at that site but directs hydroxylation to other
positions in the steroid nucleus in the case of Curvularia lunata,
whereas the presence of the fluorine in the immediate vicinity of the
favoured site of hydroxylation slowed the rate of hydroxylation at that
position but did not prevent its occurrence in the case of Rhizopus
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Table 5. Comparison of the products obtained before and after 33 45
introduction of unsaturation into a steroidal substrate '
Fungus
Calonectria
decora
Daedalea
refescens
Rhizopus
arrhizus
3S-Hydroxypregnari-3,20-dione
[98]
Products (%)
llB,15a-dihydroxy-(24)
3-CO-17B,12S,15a-
trihydroxy(8)
7a-Hydroxy-(9)
7S-Hydroxy-(9)
7S,12S-dihydroxy-(22)
7S,11a-dihydroxy-(lO)
7S-hydroxy-(8)
3S-Hydroxypregn~16-ene­
3,20-dione [99]
Products (%)
none recovered
14a,lSS-dihydroxy-(21)
7a-hydroxy- (13)
7a,lSa-dihydroxy-(12)
7-CO-15S-hydroxy-(12)
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stolonifer. Also the presence of an hydroxy group geminal to the
favoured site of hydroxylation did not appear to affect the metabolism
of that substrate when incubated with R. stolonifer.
The incubation of a substrate unsaturated at a favoured site of
hydroxylation with ~ arrhizus provided a complex mixture of products.
The isolation of both the axial and equatorial epoxide was rationalized
not as a violation of the postulation by Bloom and Shull, but as a
result of the lack of regio- and stereospecificity of the 6S-hydroxylase
enzyme.
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